Login
Toggle navigation
Videos
Categories
Trending
John Burt, chief executive of Abzena PLC
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John Burt, chief executive of Abzena PLC (LON:ABZA), pitches the company to investors.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
PT Solusi Tunas Pratama Tbk plans to increase its tower count from 1,000 in 2014 to 39,000.
00:10:00
8Common (8CO) Chairman, Nic Lim and CEO, Nick Gonios | Kah Wui “Nic” Lim, MD, 8Common Ltd8CO:ASX
00:10:00
Secrets of Cybersecurity Entrepreneurship|Zane Lackey,General Partner,Andreessen Horowitz
00:10:00
venture capital firm and the premiere investor in developer first startups|Joe Ruscio,General Partner,Heavybit
00:10:00
helping to craft the right mix of funds and individual investors for the round|Andy Dunn,Founder,Red Swan Ventures
00:10:00
Adapting to Market Shifts: Adam Sikorski on UNIMOT's Strategic Evolution in the Energy Sector | Adam Sikorski, President, Unimot SA.
00:10:00
We extremely responsive to our borrower's needs.|Samir Patel,Managing Partner,Trophy Point Capital, LLC
00:10:00
Senator Rob Portman Discusses Obamacare, Health Care Reform, and Policy Alternatives
00:10:00
Offers entrepreneurs a broad range of services to help them build their businesses|Matthew Howard,General Partner,Norwest Venture Partners
00:10:00
HongShan is committed to discovering and cultivating towering trees in the industry|Neil Shen,Investor, HongShan
00:10:00
Global Investment Powerhouse: Building Success Across Industries and Economies | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
SilverStone Mining: Driving Exploration and Production in Mexico